Pfizer Sees 2025 Revenue in Line With Wall Street Views - The Wall Street Journal


12/17/2024

Pfizer Sees 2025 Revenue in Line With Wall Street Views  The Wall Street JournalPfizer Stock Jumps On Mixed, But 'Marginally Encouraging,' 2025 Outlook  Investor's Business DailyPfizer Signals Growth in FY 2025 Guidance, Projects Revenue Up to $64 Billion  Yahoo FinancePfizer forecasts 2025 profit in line with expectations as it seeks turnaround  CNBCPfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion  Barron's...

Original

Categories: Business | Financial | Revenue | Stock

Tags: billion | business | drug | giant | guidance | journal | line | profit | rises | sees | stock | street | wall



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top